Sneẑana Šušnjar

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

Ann H. Partridge, Samuel M. Niman, Monica Ruggeri et al. · New England Journal of Medicine · 2023 · 202 citations · Full text

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Thomas Bachelot, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2019 · 111 citations · Full text

Metastatic Breast Cancer, Breast Oncology, Medicine +7

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

David Miles, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2021 · 83 citations · Full text

Prognostic Value of CA125 Kinetics and Half-Life in Advanced Ovarian Cancer

Slobodanka Čolaković, Vesna Lukić, Labuda Mitrović et al. · The International Journal of Biological Markers · 2000 · 65 citations · Full text

Surgical Oncology, Cancer Management, Pathology +19

Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy

Ann H. Partridge, Samuel M. Niman, Monica Ruggeri et al. · The Breast · 2021 · 54 citations · Full text